Developing effective endoscopic methods for treating gastroesophageal reflux disease (GERD) has proven a challenging. While current alternatives may hold promise, initial results have yet to translate into widespread adoption.
Leading experts will analyze the ongoing hurdles faced by the GI community to find effective endoscopic anti-reflux therapies when they convene at the 2019 AGA Tech Summit, to be held April 10-12 in San Francisco. Discount room rates are available at the host hotel, the Intercontinental Mark Hopkins, through March 20. Raman Muthusamy, MD, UCLA Medical Center, and chair of the AGA Center for GI Innovation and Technology, will moderate sessions focusing on:
-
- Challenges to achieving viable endoscopic anti-reflux procedures?
-
- The current opportunities that may lead to a successful breakthrough.
-
- Criteria that needs to be satisfied for a procedure(s) to gain widespread adoption.
For the past decade, the AGA Tech Summit has been the place where physician innovators, clinicians, medical technology companies, regulatory agency representatives and venture capitalists converge to discuss and explore the latest in GI technology and innovation. As an attendee, you will gain a better understanding of how technological advances will impact GI practice. You’ll also have a unique opportunity to network and collaborate with individuals who you might not meet at other venues. Save up to $175 by registering by April 8.
Do you have an idea or device and are not sure what to do next? The Tech Summit hosts an Entrepreneur?Innovator Package for GI innovators where you can have one-on-one meetings with experts in the GI space including venture capitalists, federal regulators, intellectual property attorneys, physician innovators and medical device executives. Learn more at techsummit.gastro.org.
